Press Releases

Titan Medical Inc. Announces Completion of First SPORT™ Surgical System

Dec 21, 2015

TORONTO, ON–(Marketwired – December 21, 2015) – Titan Medical Inc. (“Titan” or the “Company“) (TSX: TMD) (OTCQX: TITXF) today announced that it has built the initial SPORT™ Surgical Systems to include both the work station and the patient cart and will undergo extensive testing as a part of Engineering Verification (EV). These two EV systems will be tested to measure performance in relation to design specifications and to measure compliance with regulatory guidelines. These EV systems are precursors of the systems that will be built in early 2016 for first-in-human trials.

Dennis Fowler, EVP, Clinical and Regulatory Affairs, stated, “This fully integrated initial EV system represents the efforts of many people at Titan, our Surgeon Advisory Board and our development contractors. This is a major accomplishment for Titan as we move toward our first-in-human trials.” 

John Hargrove, Chairman and CEO of Titan Medical Inc., commented, “I am very pleased and excited that we are able to finish off the year with such a positive accomplishment. I would encourage readers to visit our web site at where we have posted pictures of this complete initial SPORT Surgical System.”

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”). The Company’s Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces for general abdominal, gynecologic, and urologic indications. For more information, visit the Company’s website at

Forward-Looking Statements

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the Company’s Annual Information Form dated March 31, 2015 (which may be viewed at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.


Titan Medical Inc.
John Hargrove
Chairman & Chief Executive Officer
(416) 548-7522 (ext. 151)

←  Back to Press Releases